398 related articles for article (PubMed ID: 19415084)
1. [Regulation of the iron metabolism].
Borch-Iohnsen B; Hagve TA; Hauge A; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):858-62. PubMed ID: 19415084
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
3. The iron driven pathway of hepcidin synthesis.
Deugnier Y
Gastroenterol Clin Biol; 2010; 34(6-7):351-4. PubMed ID: 20537480
[TBL] [Abstract][Full Text] [Related]
4. Non-HFE haemochromatosis.
Wallace DF; Subramaniam VN
World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
[TBL] [Abstract][Full Text] [Related]
5. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
6. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.
Roetto A; Camaschella C
Best Pract Res Clin Haematol; 2005 Jun; 18(2):235-50. PubMed ID: 15737887
[TBL] [Abstract][Full Text] [Related]
7. Non-HFE hepatic iron overload.
Pietrangelo A; Caleffi A; Corradini E
Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
[TBL] [Abstract][Full Text] [Related]
8. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
[TBL] [Abstract][Full Text] [Related]
9. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
10. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
Arnold J; Sangwaiya A; Bhatkal B; Arnold A
Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
[TBL] [Abstract][Full Text] [Related]
11. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
[TBL] [Abstract][Full Text] [Related]
14. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
Flanagan JM; Peng H; Beutler E
Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
[TBL] [Abstract][Full Text] [Related]
15. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.
Schmidt PJ; Toran PT; Giannetti AM; Bjorkman PJ; Andrews NC
Cell Metab; 2008 Mar; 7(3):205-14. PubMed ID: 18316026
[TBL] [Abstract][Full Text] [Related]
16. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
Shukla P; Julka S; Bhatia E; Shah S; Nagral A; Aggarwal R
Natl Med J India; 2006; 19(1):20-3. PubMed ID: 16570681
[TBL] [Abstract][Full Text] [Related]
17. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
Herrmann T; Muckenthaler M; van der Hoeven F; Brennan K; Gehrke SG; Hubert N; Sergi C; Gröne HJ; Kaiser I; Gosch I; Volkmann M; Riedel HD; Hentze MW; Stewart AF; Stremmel W
J Mol Med (Berl); 2004 Jan; 82(1):39-48. PubMed ID: 14618243
[TBL] [Abstract][Full Text] [Related]
18. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
[TBL] [Abstract][Full Text] [Related]
19. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
[TBL] [Abstract][Full Text] [Related]
20. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
